In 25 seconds you will be redirected to: Nitrosative™ and nitroscience™ are trademarks of Pharmahungary. Pharmahungary runs some in-house R&D projects for the diagnosis and therapy of cardiovascular and metabolic diseases, currently focusing e.g. on the development of inhibitors of peroxynitrite againts nitrosative stress (nitroscience™ project) and its downstream cellular target matrix metalloproteinases (MMPharma™ project) as well as activators of biglycan (biglycan™ project) for cardiovascular indications such as ischemic heart disease and atherosclerosis. Pharmahungary intends to license its new technologies and to develop joint venture R&D projects with pharmaceutical and biotechnological companies.